Similarly, Wang et al. also reported a redox-activatable liposome constructed by phospholipid-porphyrin conjugates, where IDO inhibitor NLG-8189 was embedded via hydrophilic forces, leading to the obvious augment of tumor ICD level, thus boosting the therapeutic effect of systemic anti-tumor immunity 38. This evidence concerns the gene IDO1 and neoplasm.